Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Co-primary Objectives : To evaluate the safety of combined treatment strategy of WT1-A10 + AS01B, infusions of ex vivo regulatory T cells depleted T lymphocytes and in vivo regulatory T cells depletion as post-consolidation therapy. To evaluate the safety of Treg depletion (including auto-immunity).
Critère d'inclusion
- For adult patients with WT1-positive Acute Myeloid Leukemia (AML) in CR1 (for high risk patients) or in CR2 or CR3 who are not eligible for allogeneic stem cell transplantation (SCT)